Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Operating Expenses | 6,285 | 11,055 | 2,506 | 4,110 | 6,094 |
| Operating Income | -6,285 | -11,055 | -2,506 | -4,110 | -6,094 |
| Other Income | 55 | 35 | 37 | 40 | 47 |
| Pre-tax Income | -6,229 | -11,020 | -2,469 | -4,070 | -6,047 |
| Net Income Continuous | -6,229 | -11,020 | -2,469 | -4,070 | -6,047 |
| Net Income | $-6,229 | $-11,020 | $-2,469 | $-4,070 | $-6,047 |
| EPS Basic Total Ops | -7.56 | -15.97 | -6.24 | -11.04 | -17.65 |
| EPS Basic Continuous Ops | -7.46 | -15.98 | -6.30 | -11.06 | -17.76 |
| EPS Diluted Total Ops | -7.56 | -15.97 | -6.24 | -11.04 | -17.65 |
| EPS Diluted Continuous Ops | -7.46 | -15.98 | -6.30 | -11.06 | -17.76 |
| EBITDA(a) | $-6,278 | $-11,054 | $-2,505 | $-4,109 | $-6,092 |